Cargando…
MicroRNAs and Calcium Signaling in Heart Disease
In hearts, calcium (Ca(2+)) signaling is a crucial regulatory mechanism of muscle contraction and electrical signals that determine heart rhythm and control cell growth. Ca(2+) signals must be tightly controlled for a healthy heart, and the impairment of Ca(2+) handling proteins is a key hallmark of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508866/ https://www.ncbi.nlm.nih.gov/pubmed/34638924 http://dx.doi.org/10.3390/ijms221910582 |
Sumario: | In hearts, calcium (Ca(2+)) signaling is a crucial regulatory mechanism of muscle contraction and electrical signals that determine heart rhythm and control cell growth. Ca(2+) signals must be tightly controlled for a healthy heart, and the impairment of Ca(2+) handling proteins is a key hallmark of heart disease. The discovery of microRNA (miRNAs) as a new class of gene regulators has greatly expanded our understanding of the controlling module of cardiac Ca(2+) cycling. Furthermore, many studies have explored the involvement of miRNAs in heart diseases. In this review, we aim to summarize cardiac Ca(2+) signaling and Ca(2+)-related miRNAs in pathological conditions, including cardiac hypertrophy, heart failure, myocardial infarction, and atrial fibrillation. We also discuss the therapeutic potential of Ca(2+)-related miRNAs as a new target for the treatment of heart diseases. |
---|